ES2183376T3 - Uso de lbp para el tratamiento de la septicemia. - Google Patents

Uso de lbp para el tratamiento de la septicemia.

Info

Publication number
ES2183376T3
ES2183376T3 ES98928139T ES98928139T ES2183376T3 ES 2183376 T3 ES2183376 T3 ES 2183376T3 ES 98928139 T ES98928139 T ES 98928139T ES 98928139 T ES98928139 T ES 98928139T ES 2183376 T3 ES2183376 T3 ES 2183376T3
Authority
ES
Spain
Prior art keywords
lbp
septicemia
treatment
therapeutic agents
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98928139T
Other languages
English (en)
Inventor
Ralf Reiner Schumann
Norbert Lamping
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Original Assignee
Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft filed Critical Max Delbrueck Centrum fuer Molekulare in der Helmholtz Gemeinschaft
Application granted granted Critical
Publication of ES2183376T3 publication Critical patent/ES2183376T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Saccharide Compounds (AREA)

Abstract

La invención se refiere a agentes terapéuticos para tratamiento de la septicemia, su preparación y empleo, con aplicaciones en la industria farmacéutica y en medicina. Estos agentes terapéuticos contienen como elemento esencial la proteína de unión a lipopolisacárido (LBP). La invención también se refiere a proteínas variantes, mutantes e híbridos de la LBP. Se emplea también la murina o LBP de conejo además de la LBP humana.
ES98928139T 1997-07-11 1998-04-04 Uso de lbp para el tratamiento de la septicemia. Expired - Lifetime ES2183376T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19729810A DE19729810C2 (de) 1997-07-11 1997-07-11 Mittel zur Sepsistherapie, seine Herstellung und seine Verwendung

Publications (1)

Publication Number Publication Date
ES2183376T3 true ES2183376T3 (es) 2003-03-16

Family

ID=7835437

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98928139T Expired - Lifetime ES2183376T3 (es) 1997-07-11 1998-04-04 Uso de lbp para el tratamiento de la septicemia.

Country Status (9)

Country Link
US (1) US6949512B1 (es)
EP (1) EP0999849B1 (es)
JP (1) JP2001509488A (es)
AT (1) ATE223227T1 (es)
DE (2) DE19729810C2 (es)
DK (1) DK0999849T3 (es)
ES (1) ES2183376T3 (es)
PT (1) PT999849E (es)
WO (1) WO1999002178A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2108372A1 (en) * 2008-04-09 2009-10-14 Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften Novel antimicrobial peptides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6942994A (en) * 1993-04-30 1994-11-21 Incyte Pharmaceuticals, Inc. Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
JPH08503490A (ja) * 1993-08-18 1996-04-16 モルフォシス・ゲゼルシャフト・フュア・プロタインオプティミールング・ミット・ベシュレンクテル・ハフツング リポ多糖結合性および中和能のあるペプチド
WO1995008560A1 (en) * 1993-09-24 1995-03-30 Centocor, Inc. Novel peptides useful for inhibiting binding of lipopolysaccharides (lps) by lipopolysaccharide binding protein (lbp)
US5837810A (en) * 1994-03-15 1998-11-17 The Scripps Research Institute Polypeptides of lipopolysaccharide binding protein
US5990082A (en) * 1997-10-22 1999-11-23 Xoma Corporation Uses of lipopolysaccharide binding protein

Also Published As

Publication number Publication date
WO1999002178A1 (de) 1999-01-21
DK0999849T3 (da) 2003-01-06
JP2001509488A (ja) 2001-07-24
ATE223227T1 (de) 2002-09-15
EP0999849B1 (de) 2002-09-04
DE59805440D1 (de) 2002-10-10
US6949512B1 (en) 2005-09-27
EP0999849A1 (de) 2000-05-17
DE19729810C2 (de) 2000-01-13
PT999849E (pt) 2003-01-31
DE19729810A1 (de) 1999-01-14

Similar Documents

Publication Publication Date Title
ES2128362T3 (es) Fragmentos de proteinas de prion.
DE69433666D1 (de) ENTZÜNDUNGSPROTEINE AUS MAKROPHAGEN MIP-3, MIP-4 UND MIP-1Gamma
EA199800946A1 (ru) Концентрированный препарат антител
ES2139012T3 (es) Peptidos de la proteina p53 humana destinados para ser utilizados en composiciones que inducen una reaccion en los linfocitos t humanos, y linfocitos t citotoxicos especificos de la proteina p53 humana.
ES2031806T3 (es) Factor de permeabilidad vascular humano.
ES2130120T3 (es) Procedimiento para la preparacion de la adnasa humana.
ES2068791T1 (es) Metodos y acido desoxirribonucleico para la preparacion de proteina de factor de tejido.
IT8367525A0 (it) Proteina ibrida comprendente frammenti proteici collegati da legami peptidici e relativo gene di fusione composizione contenente tale proteina
CY1112927T1 (el) Αντισωματα κατα της ανθρωπινης il-12
DK382786A (da) Overfladeaktivt rekombinant-alveolarprotein
ATE388165T1 (de) Menschliches cnp-gen und vorläuferprotein
ES2149149T1 (es) Proteinas de fijacion de interleuquina-18, su preparacion y utilizacion.
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
BR9509172A (pt) Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica
DE69520475D1 (de) Pharmaceutische Zusammensetzung von biologisch aktiven Peptiden oder Proteinen
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
ES2033747T3 (es) Preparacion de polipeptidos relacionados con factores de ligacion.
IT8468281A0 (it) Proglumide e composizioni farmaceutiche che la contengono per l impiego nella terapia di affezioni neoplastiche
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
PT639225E (pt) Polipeptidos e peptidos novos acidos nucleicos que codificam para aqueles e sua utilizacao na area da terapia tumoral inflamacao ou imunologia
DK0707473T3 (da) Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler
BR0207905A (pt) Protamina modificada com imunogenicidade reduzida
UA26313A (uk) Засіб для замісhої терапії захворюваhь дихальhих шляхів, переважhо при сиhдромі задухи
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
ES2194008T3 (es) Proteina p100 del virus del herpes humano tipo 6, las correspondientes secuencias de adn, su preparacion y uso.